|
Antipsychotic drugs, like clozapine, can stabilise some schizophrenia symptoms, but they do not cure the illness and can cause severe side effects. At UQ, a neuroscientist, a chemist and a psychiatrist have hit on a formulation that may revolutionise the treatment of schizophrenia. The research team, led by Professor Darryl Eyles and Dr Xiaoying Cui, are investigating a new delivery mode for clozapine, in the hope that it may be better tolerated by patients and improve their quality of life. In this engaging conversation, Darryl and Xiaoying discuss: - Treatment-resistant schizophrenia and the side-effects of clozapine
- Collaborating with chemists to develop intranasal delivery
- What they have found so far in preclinical studies
- The potential impact of their research on schizophrenia treatment
Related resources Epitranscriptomic regulation of striatal function: a new neurobiology of schizophrenia Schizophrenia research at QBI |